EMBC
NASDAQ · Health Care
Embecta Corp
$3.64
+0.04 (+1.11%)
Analyst Consensus
Strong Sell
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,675.0% upside
Low Target
$42.86
Average Target
$64.61
High Target
$95.95
Current Price
$3.64
Current
$3.64
$3.64
Target
$64.61
$64.61
$42.86
$64.61 avg
$95.95
Scenario Analysis
Bear Case
$42.86
1,077.5%
Low target
Base Case
$64.61
+1,675.0%
Avg target
Bull Case
$95.95
+2,536.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$15.55
-76.6% from high
52-Week Low
$3.45
+5.5% from low
Target vs 52W High
$64.61
+315.5% vs high
Peer Consensus — Health Care
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| UNH | Strong Buy | 34 | 76% | $293.85 | -22.7% |
| ISRG | Buy | 41 | 71% | $219.77 | -51.2% |
| ABT | Buy | 35 | 71% | $123.47 | +46.4% |
| SYK | Strong Buy | 37 | 76% | $338.36 | +18.5% |
| MDT | Buy | 37 | 62% | $192.46 | +152.7% |
| MCK | Strong Buy | 22 | 86% | $307.39 | -58.2% |
| CVS | Strong Buy | 33 | 76% | $162.09 | +79.0% |
| HCA | Buy | 31 | 58% | $118.82 | -72.7% |